Skip to content

Collection of FUJIFILM's 3Dimensional Mammograms

Acquisition of Mammography Images for Clinical Evaluation of FUJIFILM 3Dimensional Mammography

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01542814
Acronym
3DM
Enrollment
600
Registered
2012-03-02
Start date
2012-02-29
Completion date
2013-06-30
Last updated
2013-10-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

Screening Mammogram, Diagnostic Mammogram, Benign, Malignant, BI-RADS Categories

Brief summary

This image-acquisition study is designed to acquire the study image data and establish and document the clinical findings for each subject. The acquired data will be used to support FUJIFILM protocol FMSU2011-003B (Clinical Evaluation of FUJIFILM 3Dimensional Digital Mammography) and future regulatory submissions.

Detailed description

This is an image acquisition reader study to observe differences between 3D FujiFilm Mammography and 2D approved Mammography

Interventions

DEVICE3Dimensional Mammography

The FUJIFILM 3DM examination is a 4-view mammogram which includes CC and MLO views of each breast. For each view, a routine (0-degree) mammogram will be acquired followed immediately in the same compression by a second mammogram offset at 4 degrees.

DEVICE2D FFDM

Standard of care screening mammogram.

Sponsors

Fujifilm Medical Systems USA, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
40 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Female. * Any ethnic or racial origin. * Must come through the study via the screening or diagnostic pathway described above. * Have the ability to understand the requirements of the study, to provide written informed consent, and to comply with the study protocol. * Meet none of the

Exclusion criteria

.

Design outcomes

Primary

MeasureTime frame
Acquire screening cases with and without breast cancer.18-months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026